MARKET NEWS

Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease
 Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase 2 Study
WindMIL Therapeutics Announces Dosing of First Patient in Phase 2 Clinical Study
ARCA Biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement
Apellis Initiates Phase 1/2 Study of APL-9 in Patients With Severe COVID-19

  FEATURED EDITORIAL

  COMPANY PROFILE

Headquartered in the heart of the Swiss Alps, Datwyler Sealing Solutions is a leading industrial supplier and key player in global markets for system-critical components in healthcare, automotive, and general industry. The healthcare market segment provides state-of-the-art solutions for parenteral drug and medical device packaging. Datwyler Sealing Solutions is a leading manufacturer and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices are built on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services, including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Evonik Launches Platform of Custom Functional Excipients to Precisely Control the Release Profile of Parenteral Drug Products

Evonik Launches Platform of Custom Functional Excipients to Precisely Control the Release Profile of Parenteral Drug Products

Evonik recently announced the launch of the RESOMER Precise platform of custom functional polymeric excipients to allow pharmaceutical companies to control…

Junshi Biosciences & Merck Announce Collaboration to Explore Promising New Combination Treatment

Junshi Biosciences & Merck Announce Collaboration to Explore Promising New Combination Treatment

Junshi Biosciences and Merck recently announced their collaboration on a clinical trial program designed to investigate the efficacy and safety of…

Thermo Fisher Scientific & CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services

Thermo Fisher Scientific & CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services

Thermo Fisher Scientific Inc. and CSL Limited recently announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also….

NOVA Thin Film Pharmaceuticals & Quality Chemical Laboratories Announce Partnership in Formation & Commencement of Soluble Thin Film Operations

NOVA Thin Film Pharmaceuticals & Quality Chemical Laboratories Announce Partnership in Formation & Commencement of Soluble Thin Film Operations

NOVA Thin Film Pharmaceuticals LLC (NTFP) recently announced its formation and the commencement of its soluble thin film operations……

WEBINAR ALERT- From Diluent to Differentiator: How to Choose a Diluent System That Differentiates Your Lyophilized Product

WEBINAR ALERT- From Diluent to Differentiator: How to Choose a Diluent System That Differentiates Your Lyophilized Product

Along with a rapidly expanding global market for innovative lyophilized biologics come increased cost and competitive pressures. Today, it is critical that….

Wondering if Investing in a Higher Purity Excipient is Really Going to Pay Off?

Wondering if Investing in a Higher Purity Excipient is Really Going to Pay Off?

Wondering if investing in a higher purity excipient is really going to pay off? Check out our video web series where we speak to 3 subject matter experts on the benefits of…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 17 – Parenteral Contract Manufacturing
June 24 – Controlled Release